Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Long-Term Investments (2020 - 2021)

Historic Long-Term Investments for Xeris Biopharma Holdings (XERS) over the last 2 years, with Q3 2021 value amounting to $33.5 million.

  • Xeris Biopharma Holdings' Long-Term Investments changed N/A to $33.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $33.5 million, marking a year-over-year change of. This contributed to the annual value of $96.2 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q3 2021, Xeris Biopharma Holdings' Long-Term Investments is $33.5 million.
  • Over the past 5 years, Xeris Biopharma Holdings' Long-Term Investments peaked at $96.2 million during Q4 2020, and registered a low of $33.5 million during Q3 2021.